Skip to main content
PMC home page
Gut logoLink to Gut
. 1993 Jan;34(1):51–55. doi: 10.1136/gut.34.1.51

Adsorbents as antiendotoxin agents in experimental colitis.

K R Gardiner 1, N H Anderson 1, M D McCaigue 1, P J Erwin 1, M I Halliday 1, B J Rowlands 1
PMCID: PMC1374100  PMID: 8432452

Abstract

The intestinal mucosa protects the body from a large reservoir of intraluminal pathogenic bacteria and endotoxins. This mucosal barrier is disrupted by the inflammation and ulceration of inflammatory bowel disease and may permit the absorption of toxic bacterial products. Systemic endotoxaemia has been demonstrated in ulcerative colitis and Crohn's disease and correlates with the extent and activity of disease. In this study the efficacy of absorbents as antiendotoxin agents in a hapten induced rat model of colitis is investigated. Induction of colitis was associated with systemic endotoxaemia. Enteral administration of terra fullonica and kaolin, but not of charcoal, significantly reduced systemic endotoxaemia (terra fullonica 4.2 (1.40) pg/ml; kaolin 5.29 (1.86) pg/ml; charcoal 32.7 (16.6) pg/ml; water 39.8 (12.6) pg/ml). Data expressed as mean (SE). With increasing severity of colitis, there was a decreasing ability of adsorbent therapy (terra fullonica) to control systemic endotoxaemia. Enteral administration of adsorbents controls gut derived systemic endotoxaemia in experimental colitis in animals and may be a useful antiendotoxin treatment in patients with inflammatory bowel disease.

Full text

PDF
51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki K. A study of endotoxemia in ulcerative colitis and Crohn's disease. I. Clinical study. Acta Med Okayama. 1978 Jun;32(2):147–158. [PubMed] [Google Scholar]
  2. Aoki K. A study of endotoxemia in ulcerative colitis and Crohn's disease. II. Experimental study. Acta Med Okayama. 1978 Jul;32(3):207–216. [PubMed] [Google Scholar]
  3. Bende S., Bertók L. Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock. Circ Shock. 1986;19(2):239–244. [PubMed] [Google Scholar]
  4. Busch J., Hammer M., Brunkhorst R., Wagener P. Endotoxinbestimmung bei entzündlich-rheumatischen Erkrankungen--Der Einfluss nichtsteroidaler Antiphlogistika auf die Darmpermeabilität. Z Rheumatol. 1988 May-Jun;47(3):156–160. [PubMed] [Google Scholar]
  5. Colin R., Grancher T., Lemeland J. F., Hecketsweiler P., Galmiche J. P., Le Grix A., Geffroy Y. Recherche d'une endotoxinémie dans les entéro-colites inflammatoires cryptogénétiques. Gastroenterol Clin Biol. 1979 Jan;3(1):15–19. [PubMed] [Google Scholar]
  6. Ditter B., Urbaschek R., Urbaschek B. Ability of various adsorbents to bind endotoxins in vitro and to prevent orally induced endotoxemia in mice. Gastroenterology. 1983 Jun;84(6):1547–1552. [PubMed] [Google Scholar]
  7. Gathiram P., Wells M. T., Brock-Utne J. G., Wessels B. C., Gaffin S. L. Oral administered nonabsorbable antibiotics prevent endotoxemia in primates following intestinal ischemia. J Surg Res. 1988 Aug;45(2):187–193. doi: 10.1016/0022-4804(88)90064-9. [DOI] [PubMed] [Google Scholar]
  8. Gathiram P., Wells M. T., Brock-Utne J. G., Wessels B. C., Gaffin S. L. Prevention of endotoxaemia by non-absorbable antibiotics in heat stress. J Clin Pathol. 1987 Nov;40(11):1364–1368. doi: 10.1136/jcp.40.11.1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jacob A. I., Goldberg P. K., Bloom N., Degenshein G. A., Kozinn P. J. Endotoxin and bacteria in portal blood. Gastroenterology. 1977 Jun;72(6):1268–1270. [PubMed] [Google Scholar]
  10. Juhlin L., Krause U., Shelley W. B. Endotoxin-induced microclots in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1980;15(3):311–314. doi: 10.3109/00365528009181475. [DOI] [PubMed] [Google Scholar]
  11. Kelley C. J., Ingoldby C. J., Blenkharn J. I., Wood C. B. Colonoscopy related endotoxemia. Surg Gynecol Obstet. 1985 Oct;161(4):332–334. [PubMed] [Google Scholar]
  12. Kirkin B. V., Fomin S. A., Ivanov A. F., Eroshkina T. D., Mussin I. I., Khalif I. L., Chirkin V. V., Tabachnik A. L. Efficiency of hemosorption in treatment of patients with ulcerative colitis. Biomater Artif Cells Artif Organs. 1987;15(1):271–279. doi: 10.3109/10731198709118527. [DOI] [PubMed] [Google Scholar]
  13. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989 Mar;96(3):795–803. [PubMed] [Google Scholar]
  14. Nolan J. P., Ali M. V. Effect of cholestyramine on endotoxin toxicity and absorption. Am J Dig Dis. 1972 Feb;17(2):161–166. doi: 10.1007/BF02232738. [DOI] [PubMed] [Google Scholar]
  15. Nolan J. P. Endotoxin, reticuloendothelial function, and liver injury. Hepatology. 1981 Sep-Oct;1(5):458–465. doi: 10.1002/hep.1840010516. [DOI] [PubMed] [Google Scholar]
  16. Palmer K. R., Duerden B. I., Holdsworth C. D. Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut. 1980 Oct;21(10):851–854. doi: 10.1136/gut.21.10.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Prytz H., Holst-Christensen J., Korner B., Liehr H. Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol. 1976;11(8):857–863. [PubMed] [Google Scholar]
  18. Rolandelli R. H., Saul S. H., Settle R. G., Jacobs D. O., Trerotola S. O., Rombeau J. L. Comparison of parenteral nutrition and enteral feeding with pectin in experimental colitis in the rat. Am J Clin Nutr. 1988 Apr;47(4):715–721. doi: 10.1093/ajcn/47.4.715. [DOI] [PubMed] [Google Scholar]
  19. Tai C. Clinical and experimental endotoxemia related to the intestinal ischemia detection of endotoxin by means of radioimmunoassay. Jpn J Med Sci Biol. 1974 Apr;27(2):111–114. [PubMed] [Google Scholar]
  20. Wallace J. L., MacNaughton W. K., Morris G. P., Beck P. L. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989 Jan;96(1):29–36. doi: 10.1016/0016-5085(89)90760-9. [DOI] [PubMed] [Google Scholar]
  21. Wellmann W., Fink P. C., Benner F., Schmidt F. W. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut. 1986 Jul;27(7):814–820. doi: 10.1136/gut.27.7.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wellmann W., Fink P. C., Schmidt F. W. Whole-gut irrigation as antiendotoxinaemic therapy in inflammatory bowel disease. Hepatogastroenterology. 1984 Apr;31(2):91–93. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES